Details of HTA journal title
Last updated: 2 February 2010 - Next update due: 9 February 2010
Research type: |
HTA Technology Assessment Report |
Title (lead author) etc: |
Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation (Jones) 196 pages, Volume 13, number 35 |
DOI |
10.3310/hta13350 |
View/print executive summary
View/print abstract
View full text in pdf format (1039 KB) This title is available on our CD-ROM of the journal. Order a CD-ROM - free of charge worldwide.
Go to our correspondence page to comment on this publication
|
|
Headline: |
Study found that both adefovir dipivoxil and pegylated interferon alpha are beneficial for patients with chronic hepatitis B in terms of suppressing viral load, reducing liver damage-associated biochemical activity, inducing HBeAg seroconversion, and reducing liver fibrosis and necroinflammation |
Project ref: |
07/15/01 |
Original project title: |
Adefovir dipivoxil and pegylated interferon alfa for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation |
Chief Investigator: |
Southampton Health Technology Assessment Centre (SHTAC), University of Southampton |
Start Date: |
December 2007 |
Publication date: |
July 2009 |
Cost: |
This project was commissioned by the HTA programme on a call-off contract basis. |
Project Protocol: |
Project protocol not available |
Printed copies of this title despatched: |
100 (Figures relate to the previous calendar month) |
Downloads/Views of electronic version from website: |
5906 (Figures are cumulative.) Last updated 12th January 2010. |
URL of this page: |
http://www.hta.ac.uk/1718 |
News feeds